MARC details
000 -LEADER |
fixed length control field |
02065nam a22002297a 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
CUTN |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20201005161136.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
201005b ||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780120066957 |
041 ## - LANGUAGE CODE |
Language |
English |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
Edition number |
22 |
Classification number |
616.9940072 |
Item number |
VAN |
100 ## - MAIN ENTRY--PERSONAL NAME |
Personal name |
Vande Woude, George F. |
245 ## - TITLE STATEMENT |
Title |
Advances in Cancer Research Vol .95 : |
Statement of responsibility, etc |
Edited by George F. Vande Woude and George Klein |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
London : |
Name of publisher, distributor, etc |
Academic Press, |
Date of publication, distribution, etc |
2006. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xi, 358 p. : |
Other physical details |
ill. ; |
505 ## - FORMATTED CONTENTS NOTE |
Title |
NY-ESO-1: Review of an Immunogenic Tumor Antigen. |
-- |
Order, Disorder, Death: Lessons from a Superorganism. |
-- |
Control of Differentiation in Progression of Epithelial Tumors. |
-- |
Cancer Vaccines: Preclinical Studies and Novel Strategies. |
-- |
Clinical Results of Vaccine Therapy for Cancer: Learning from History for Improving the Future. |
-- |
Immunodominance and Immunodomination: Critical Factors in Developing Effective CD8+ T-Cell Based Cancer Vaccines. |
-- |
NK Cell Receptors as Tools in Cancer Immunotherapy. |
-- |
Innate Immune Recognition and Suppression of Tumors. |
-- |
Inhibitors of the HSP90 Molecular Chaperone: Current Status. |
520 ## - SUMMARY, ETC. |
Summary, etc |
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics including NY-ESO-1: review of an immunogenic tumor antigen; Order, disorder, death: lessons from a superorganism; Control of differentiation in progression of epithelial tumors; Cancer vaccines: preclinical studies and novel strategies; Clinical results of vaccine therapy for cancer: learning from history for improving the future; Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell based cancer vaccines; NK cell receptors as tools in cancer immunotherapy; Innate immune recognition and suppression of tumors; Inhibitors of the HSP90 molecular chaperone: current status. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Cancer Research |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Clinical Result |
700 ## - ADDED ENTRY--PERSONAL NAME |
Personal name |
Klein, George. |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
Reference Books |